Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

The Intersection of Pharma and Tech: Digital Pharma

Posted on October 19th, 2016 by in Pharma R&D

For years, the pharmaceutical or biopharma industry and the information technology (IT) sector seemed to be more or less separate entities. This has certainly changed in more recent times. Continue reading “The Intersection of Pharma and Tech: Digital Pharma” »

Impact of Precision Medicine and Genomics on Patient Treatment

Posted on August 26th, 2016 by in Chemistry

In January of 2015, President Barack Obama launched the Precision Medicine Initiative, which brought to the forefront the growing understanding and need for individually tailored and customized treatments for patients.

Continue reading “Impact of Precision Medicine and Genomics on Patient Treatment” »

Advancing the Development and Clinical Use of Biomarkers

Posted on June 21st, 2016 by in Pharma R&D

Biomarker-based patient selection for clinical trials, a hallmark of precision medicine, is gaining traction. On Monday June 6, a team of researchers reported at the American Society of Clinical Oncology annual meeting and in an online paper in JAMA Oncology that biomarker selection results in better outcomes in Phase l trials. Continue reading “Advancing the Development and Clinical Use of Biomarkers” »

Innovative Repurposing: New Drugs From Old

Posted on May 26th, 2016 by in Chemistry

Re-purposing of drugs is fraught with challenges, but can they be overcome so that patients benefit? The term re-purposing is often associated with the idea of saving a few bucks by taking something old and turning it into something useful (like transforming an empty wine bottle into a bird feeder). In the pharmaceutical world, though Continue reading “Innovative Repurposing: New Drugs From Old” »